Heart Failure Program

The Heart Failure Program at the Smidt Heart Institute is among the most comprehensive programs in the nation. Led by Michele Hamilton, MD, and Jon Kobashigawa, MD, the program offers a team approach and holistic treatment for patients coping with advanced heart failure and cardiomyopathy.

Heart failure happens when the heart muscle fails to pump as much blood as the body needs. Cardiomyopathy is a condition characterized by the wall of the heart muscle becoming thick, enlarged or stiff. We take care of patients with all types of cardiomyopathy, including hypertrophic, familial, peripartum, amyloidosis and chemotherapy-related. Our expert team leads the way in treating the most rare and complex cases.

Qualified patients can engage in clinical trials for stem cell therapy and surgically implanted mechanical devices that can save and extend lives.

Coping with advanced disease can be a challenge medically, financially and emotionally. The Heart Failure Program offers support in all of these areas, ensuring our patients are as healthy—and happy—as possible.

Resisting Heart Failure

A retired educator and Marine tapped deep reserves of strength to survive heart failure. Now he has a new heart and teaches his brand of resilience to the next generation.

Cardiac Amyloidosis Treatments

Cardiac amyloidosis is a condition often overlooked in medicine. But at the Smidt Heart Institute, our cardiologists and cardiac surgeons specialize in diagnosing and treating this rare condition, which often leads to heart failure.

Program Director

Michele A. Hamilton, MD

"Patients with the most advanced and complex forms of heart failure come to us for our expertise, state-of-the-art treatments and team approach to care."